| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |